USA flag logo/image

An Official Website of the United States Government

Malarial Vaccines Utilizing Antigen/Adjuvant Display on Viral-Like Particles

Award Information

Agency:
Department of Defense 		Branch:
N/A 		Award ID:
 Program Year/Program:
2011 / SBIR
Agency Tracking Number:
A2-4234 		Solicitation Year:
2009 		Solicitation Topic Code:
A09-107 		Solicitation Number:
2009.2
Small Business Information
Agave BioSystems, Inc.
P.O. Box 100 Ithaca, NY -
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 2
Fiscal Year: 2011
Title: Malarial Vaccines Utilizing Antigen/Adjuvant Display on Viral-Like Particles
Agency: DOD
Contract: W81XWH-10-C-0005
Award Amount: $629,510.00
 

Abstract:

Recent studies have suggested the potential of improved malarial vaccines by use of the viral-like particle (VLP)-linked immunogen approach. The VLP technology is being utilized for the development of vaccines for a variety of diseases. Agave BioSystems is creating a novel platform for development of malarial vaccines consisting of a VLP displayed malarial antigen/adjuvant based on the Norwalk virus (NV) capsid protein. The VLP will be engineered to express a candidate antigen in combination with a peptide adjuvant. These VLPs will be characterized, purified and delivered for testing of efficacy to stimulate cellular and humoral immune responses.In the Phase I, Agave BioSystems successfully demonstrated proof-of concept for this novel platform.

Principal Investigator:

Mehran Pazirandeh
Staff Scientist
(607) 272-0002
mehranp@agavebio.com

Business Contact:

Noe Salazar
President
(512) 373-8601
nsalazar@agavebio.com
Small Business Information at Submission:

Agave BioSystems, Inc.
P.O. Box 100 Ithaca, NY -

EIN/Tax ID: 161551819
DUNS: N/A
Number of Employees:
Woman-Owned: No
Minority-Owned: Yes
HUBZone-Owned: Yes